Conmed CNMD
NYSE CNMD
$46.99 +0.40 (+0.86%)
As of: Sep 9, 2026 · 3:59 PM EDT

Conmed (CNMD) Revenue Growth (1y) (2011 - 2026)

Analysis

Conmed (CNMD) Revenue Growth (1y) (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (1y) (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn 13.02%
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 18.54%
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 13.73%
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 9.42%
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 7.53%
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 13.63%
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn 7.95%
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 13.08%
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn 7.30%
10 Conmed 1.48 Bn 1.44 Bn 197.46 Mn 0.33%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.33%
Mar 31, 2026 -1.31%
Dec 31, 2025 7.88%
Sep 30, 2025 6.70%
Jun 30, 2025 3.09%
Mar 31, 2025 2.88%
Dec 31, 2024 5.78%
Sep 30, 2024 3.98%
Jun 30, 2024 4.55%
Mar 31, 2024 5.69%
Dec 31, 2023 30.37%
Sep 30, 2023 10.72%
Jun 30, 2023 14.60%
Mar 31, 2023 21.93%
Dec 31, 2022 -8.43%
Sep 30, 2022 10.55%
Jun 30, 2022 8.63%
Mar 31, 2022 4.15%
Dec 31, 2021 8.36%
Sep 30, 2021 4.62%